{"id":450542,"date":"2023-01-30T17:59:13","date_gmt":"2023-01-31T01:59:13","guid":{"rendered":"https:\/\/nai500.com\/?p=450542"},"modified":"2023-01-30T17:59:13","modified_gmt":"2023-01-31T01:59:13","slug":"2023%e5%b9%b4%e8%bf%99%e4%ba%9b%e4%bd%8e%e9%a3%8e%e9%99%a9%e7%9a%84%e7%be%8e%e8%82%a1%e7%99%8c%e7%97%87%e8%82%a1%e7%a5%a8%e5%85%b3%e6%b3%a8%e8%b5%b7%e6%9d%a5","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2023\/01\/2023%e5%b9%b4%e8%bf%99%e4%ba%9b%e4%bd%8e%e9%a3%8e%e9%99%a9%e7%9a%84%e7%be%8e%e8%82%a1%e7%99%8c%e7%97%87%e8%82%a1%e7%a5%a8%e5%85%b3%e6%b3%a8%e8%b5%b7%e6%9d%a5\/","title":{"rendered":"\u4eba\u7c7b\u5065\u5eb7\u7684\u201c\u5934\u53f7\u6740\u624b\u201d\uff1a2023\u5e74\u8fd9\u4e9b\u4f4e\u98ce\u9669\u7684\u7f8e\u80a1\u764c\u75c7\u80a1\u7968\u5173\u6ce8\u8d77\u6765"},"content":{"rendered":"

\u764c\u75c7\u7ed9\u4eba\u7c7b\u5065\u5eb7\u4ee5\u53ca\u533b\u7597\u4f53\u7cfb\u90fd\u5e26\u6765\u4e86\u5de8\u5927\u7684\u538b\u529b\u30022023\u5e74\u7f8e\u56fd\u9884\u8ba1\u65b0\u8bca\u65ad\u764c\u75c7\u6570\u91cf\u5c06\u8d85\u8fc7190\u4e07\uff0c\u764c\u75c7\u6b7b\u4ea1\u4eba\u6570\u9884\u8ba1\u5c06\u8d85\u8fc760\u4e07\u3002\u6b64\u5916\uff0c\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5dde\u7acb\u533b\u5b66\u9662\u7684\u7814\u7a76\u6570\u636e\u663e\u793a\uff0c2018\u5e74\u7f8e\u56fd\u524d15\u79cd\u764c\u75c7\u7684\u6210\u672c\u8d85\u8fc7$1560\u4ebf\uff0c\u7f8e\u56fd\u56fd\u5bb6\u764c\u75c7\u7814\u7a76\u6240\uff08NCI\uff09\u9884\u8ba1\u764c\u75c7\u76f8\u5173\u7684\u533b\u7597\u6210\u672c\u52302030\u5e74\u5c06\u66b4\u589e\u81f3$2460\u4ebf\u3002<\/p>\n

\u6311\u6218\u4e0e\u673a\u4f1a\u5e76\u5b58\uff0c\u800c\u764c\u75c7\u6b63\u662f\u8fd9\u6837\u4e00\u4e2a\u5e9e\u5927\u7684\u5e02\u573a\u673a\u4f1a\u3002\u65e0\u8bba\u5927\u5c0f\u516c\u53f8\uff0c\u73b0\u5728\u90fd\u5728\u79ef\u6781\u5f00\u53d1\u65b0\u7684\u764c\u75c7\u8bca\u65ad\u548c\u6cbb\u7597\u624b\u6bb5\uff0c\u5176\u4e2d\u5c31\u5b55\u80b2\u4e86\u5de8\u5927\u7684\u7f8e\u56fd\u80a1\u5e02\u764c\u75c7\u80a1\u7968\u7684\u957f\u671f\u6295\u8d44\u673a\u4f1a\u3002<\/p>\n

\u4f4e\u98ce\u9669\u7684\u7f8e\u80a1\u764c\u75c7\u80a1\u7968<\/h2>\n

\u6709\u5f88\u591a\u5c0f\u578b\u7684\u5236\u836f\u5546\u4e5f\u4e13\u6ce8\u4e8e\u764c\u75c7\u6cbb\u7597\uff0c\u4f46\u8fd9\u7c7b\u521d\u671f\u7684\u751f\u7269\u79d1\u6280\u80a1\u6ce2\u52a8\u548c\u98ce\u9669\u90fd\u592a\u9ad8\uff0c\u56e0\u6b64\u5e76\u4e0d\u9002\u5408\u7edd\u5927\u591a\u6570\u7684\u6295\u8d44\u8005\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u4e0b\u9762\u8fd94\u53ea\u764c\u75c7\u80a1\u7968\u7684\u98ce\u9669\u5c31\u8981\u5c0f\u5f97\u591a\u3002<\/p>\n\n\n\n\n\n\n\n\n
\u516c\u53f8<\/td>\n\u5e02\u503c<\/td>\n\u805a\u7126\u9886\u57df<\/td>\n<\/tr>\n<\/thead>\n
\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9dBristol-Myers Squibb\uff08NYSE:BMY\uff09<\/td>\n$1540\u4ebf<\/td>\n\u80bf\u7624\u3001\u514d\u75ab\u548c\u5fc3\u8840\u7ba1\u75be\u75c5<\/td>\n<\/tr>\n
Guardant Health (NASDAQ:GH)<\/td>\n$30\u4ebf<\/td>\n\u6db2\u4f53\u6d3b\u68c0<\/td>\n<\/tr>\n
Illumina (NASDAQ:ILMN)<\/td>\n$340\u4ebf<\/td>\n\u57fa\u56e0\u6d4b\u5e8f\u548c\u6db2\u4f53\u6d3b\u68c0<\/td>\n<\/tr>\n
\u8f89\u745e\u5236\u836fPfizer\uff08NYSE:PFE\uff09<\/td>\n$2460\u4ebf<\/td>\n\u80bf\u7624\u3001\u514d\u75ab\u3001\u5fc3\u8840\u7ba1\u75be\u75c5\u3001\u7f55\u89c1\u75c5\u4ee5\u53ca\u75ab\u82d7<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u6570\u636e\u622a\u81f32023\u5e741\u670827\u65e5<\/em><\/p>\n

\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d<\/h3>\n

\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9dBristol-Myers Squibb\uff08NYSE:BMY\uff09<\/a>\u76ee\u524d\u62e5\u67095\u6b3e\u4e0a\u5e02\u4e14\u5e74\u9500\u552e\u989d\u4e0d\u4f4e\u4e8e$10\u4ebf\u7684\u6297\u764c\u836f\u7269\uff0c\u5176\u4e2d\u6700\u7545\u9500\u7684\u4ea7\u54c1\u662f\u8840\u764c\u7528\u836fRevlimid\u3002\u6b64\u5916\uff0cOpdivo\u548cLAG3\u6291\u5236\u5242relatlimab\u7684\u7ec4\u5408\u514d\u75ab\u7597\u6cd5\u7684\u5cf0\u503c\u9500\u552e\u989d\u6709\u671b\u8d85\u8fc7$40\u4ebf\uff0c\u8840\u764c\u836f\u7269Abecma\u548cBreyanzi\u4e5f\u6709\u53ef\u80fd\u5728\u672a\u6765\u51e0\u5e74\u65f6\u95f4\u91cc\u6210\u4e3a\u91cd\u78c5\u836f\u3002\u9664\u4e86\u764c\u75c7\uff0c\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u540c\u65f6\u8fd8\u662f\u5fc3\u8840\u7ba1\u75be\u75c5\uff08\u53e3\u670d\u6297\u51dd\u836f\u827e\u4e50\u59a5\uff09\u548c\u514d\u75ab\u6cbb\u7597\uff08Orencia\u548cZeposia\uff09\u9886\u57df\u7684\u9886\u5bfc\u8005\u3002<\/p>\n

Guardant Health<\/h3>\n

\u6db2\u4f53\u6d3b\u68c0\u5148\u884c\u8005Guardant Health Inc.\uff08NASDAQ:GH\uff09<\/a>\u65d7\u4e0b\u7684Guardant360 CDx\u662f\u7b2c\u4e00\u6b3e\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\u9002\u7528\u4e8e\u6240\u6709\u665a\u671f\u5b9e\u4f53\u7624\u7684\u6db2\u4f53\u6d3b\u68c0\u4ea7\u54c1\uff0c\u540c\u65f6\u8be5\u4ea7\u54c1\u8fd8\u53ef\u4ee5\u7528\u4e8e\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u7684\u4f34\u968f\u8bca\u65ad\u3002\u6b64\u5916\uff0c\u8be5\u516c\u53f8\u8fd8\u62e5\u6709\u7ec4\u7ec7\u6d3b\u68c0\u4ea7\u54c1Guardant360 TissueNext\uff0c\u80bf\u7624\u68c0\u6d4b\u4ea7\u54c1Guardant360 Response\uff0c\u4ee5\u53ca\u8840\u6db2\u68c0\u6d4b\u4ea7\u54c1Guardant Reveal\u3002\u8be5\u516c\u53f8\u6bcf\u5e74\u5728\u764c\u75c7\u6cbb\u7597\u65b9\u6848\u7b5b\u9009\u4ee5\u53ca\u590d\u53d1\u76d1\u6d4b\u9886\u57df\u603b\u7684\u6f5c\u5728\u5e02\u573a\u89c4\u6a21\u7ea6\u4e3a$300\u4ebf\uff0c\u800c\u65e9\u671f\u764c\u75c7\u68c0\u6d4b\u7684\u5e02\u573a\u673a\u4f1a\u66f4\u662f\u63a5\u8fd1$1000\u4ebf\u3002Guardant Health\u7684Shield\u6709\u671b\u6210\u4e3a\u9996\u4e2a\u83b7\u5f97FDA\u6279\u51c6\u4e14\u533b\u4fdd\u627f\u4fdd\u7684\u591a\u764c\u75c7\u68c0\u6d4b\u4ea7\u54c1\u3002<\/p>\n

Illumina<\/h3>\n

2021\u5e74\uff0c\u6db2\u4f53\u6d3b\u68c0\u4ee5\u53ca\u57fa\u56e0\u6d4b\u5e8f\u5de8\u5934Illumina Inc\uff08NASDAQ:ILMN\uff09<\/a>\u5b8c\u6210\u5bf9Grail\u7684\u6536\u8d2d\uff0c\u5c06\u6db2\u4f53\u6d3b\u68c0\u4ea7\u54c1Galleri\u6536\u5165\u56ca\u4e2d\uff0c\u540c\u65f6\u501f\u52a9\u4f34\u968f\u8bca\u65ad\u68c0\u6d4b\u4ea7\u54c1TruSight\u6253\u5165\u764c\u75c7\u6cbb\u7597\u7b5b\u9009\u5e02\u573a\u3002\u4e0d\u8fc7\uff0cIllumina\u5728\u6297\u764c\u9886\u57df\u63d0\u4f9b\u7684\u6700\u5927\u4ef7\u503c\u8fd8\u662f\u6765\u81ea\u4e8e\u4ed6\u7684\u57fa\u56e0\u6d4b\u5e8f\u7cfb\u7edf\uff0cIllumina\u6d4b\u5e8f\u7cfb\u7edf\u7684\u5168\u7403\u5b89\u88c5\u91cf\u5df2\u8d852\u4e07\u53f0\u3002\u9664\u4e86\u764c\u75c7\u7814\u7a76\uff0cIllumina\u7684\u6280\u672f\u8fd8\u5e7f\u6cdb\u5e94\u7528\u4e8e\u57fa\u56e0\u548c\u4f20\u67d3\u6027\u75be\u75c5\u3001\u65e0\u521b\u4ea7\u524d\u68c0\u6d4b\uff08NIPT\uff09\u3001\u836f\u7269\u53d1\u73b0\u4ee5\u53ca\u86cb\u767d\u8d28\u7ec4\u7684\u7814\u7a76\u3002<\/p>\n

\u8f89\u745e<\/h3>\n

\u8f89\u745e\u5236\u836fPfizer\uff08NYSE:PFE\uff09<\/a>\u76ee\u524d\u5728\u552e3\u6b3e\u91cd\u78c5\u80bf\u7624\u836f\u7269\uff1a\u4e73\u817a\u764c\u836f\u7269Ibrance\u3001\u524d\u5217\u817a\u764c\u836f\u7269Xtandi\u4ee5\u53ca\u80be\u764c\u836f\u7269Inlyta\u3002\u6b64\u5916\uff0c\u8be5\u516c\u53f8\u8fd8\u62e5\u6709\u53e6\u591610\u591a\u6b3e\u5e74\u9500\u552e\u989d\u4e0d\u4f4e\u4e8e$1.00\u4ebf\u7684\u6297\u764c\u836f\u3002\u764c\u75c7\u540c\u65f6\u4e5f\u662f\u8f89\u745e\u5728\u7814\u836f\u7269\u7684\u6838\u5fc3\uff0c30\u591a\u4e2a\u80bf\u7624\u9879\u76ee\u5904\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u9636\u6bb5\uff0c\u6bd4\u5982\u8bf4\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u8bd5\u9a8c\u836f\u7269elranatamab\u3002\u9664\u4e86\u81ea\u7814\uff0c\u8be5\u5236\u836f\u5de8\u5934\u8fd8\u501f\u52a9\u81ea\u8eab\u5e9e\u5927\u7684\u73b0\u91d1\u8fdb\u884c\u5404\u79cd\u6536\u8d2d\uff0c\u6bd4\u5982\u8bf42021\u5e74\u6536\u8d2d\u7684Trillium Therapeutics\uff08\u8840\u764c\u9879\u76ee\uff09\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u764c\u75c7\u7ed9\u4eba\u7c7b\u5065\u5eb7\u4ee5\u53ca\u533b\u7597\u4f53\u7cfb\u90fd\u5e26\u6765\u4e86\u5de8\u5927\u7684\u538b\u529b\u30022023\u5e74\u7f8e\u56fd\u9884\u8ba1\u65b0\u8bca\u65ad\u764c\u75c7\u6570\u91cf\u5c06\u8d85\u8fc7190\u4e07\uff0c\u764c\u75c7\u6b7b\u4ea1\u4eba\u6570\u9884\u8ba1 […]<\/p>\n","protected":false},"author":27,"featured_media":450543,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[513,455,747,925],"class_list":["post-450542","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-513","tag-455","tag-747","tag-925","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/450542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=450542"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/450542\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/450543"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=450542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=450542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=450542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}